欢迎访问《中国真菌学杂志》杂志官方网站,今天是 分享到:

中国真菌学杂志 2022, Vol. 17  Issue (6): 461-466.

论著 上一篇    下一篇

44例马尔尼菲篮状菌感染患者的临床特征及预后分析

邱付兰1, 邱树胜2, 林燕青3, 刘辉1, 钟荣荣4   

  1. 1. 福建医科大学附属龙岩第一医院检验科, 龙岩 364000;
    2. 福建省龙岩市第二医院药剂科, 龙岩 364000;
    3. 福建省龙岩市第二医院检验科, 龙岩 364000;
    4. 福建医科大学附属龙岩第一医院急诊科, 龙岩 364000
  • 收稿日期:2022-04-26 发布日期:2023-01-04
  • 通讯作者: 钟荣荣,E-mail:welcomezrr@sina.com E-mail:welcomezrr@sina.com
  • 作者简介:邱付兰,女(汉族),本科,副主任技师.E-mail:fjqfl9933@163.com
  • 基金资助:
    福建省自然科学基金(2018J01408)

Clinical characteristics and prognosis of 44 patients with Talaromyces marneffei infection

QIU Fulan1, QIU Shusheng2, LIN Yanqing3, LIU Hui1, ZHONG Rongrong4   

  1. 1. Department of Laboratory Medicine, Longyan Frist Hospital Affiliated to Fujian Medical University, longyan 364000, China;
    2. Department of pharmacy, Longyan second hospital, Fujian Province, longyan 364000, China;
    3. Department of Laboratory Medicine, Longyan second hospital, Fujian Province, longyan 364000, China;
    4. Department of Emergency, Longyan Frist Hospital Affiliated to Fujian Medical University, longyan 364000, China
  • Received:2022-04-26 Published:2023-01-04

摘要: 目的 了解福建龙岩地区马尔尼菲篮状菌感染的临床特点及预后,为尽早识别该病并进行有效的治疗提供参考依据。方法 收集2017年1月至2021年11月福建医科大学附属龙岩第一医院和龙岩市第二医院收治44例马尔尼菲篮状菌感染的患者资料,包括患者一般资料、临床表现、实验室检查结果、影像学改变、菌种鉴定及药敏试验、治疗与预后。两组间比较采用χ2检验或曼-惠特尼U检验。结果 44例患者中人类免疫缺陷病毒(HIV)阳性和阴性各22例,两组在发病年龄段、临床症状、白细胞(WBC)、CD4+T淋巴细胞、血红蛋白(HB)、血小板(PLT)、谷草转氨酶(AST)、谷丙转氨酶(ALT)、白蛋白(ALB)与降钙素原(PCT)存在统计学差异,95.4%的HIV合并马尔尼菲篮状菌病(TSM)患者的CD4+T淋巴细胞<50个/μL,且以播散型TSM为主,而HIV阴性组以局限型为主。血清1-3-β-D葡聚糖(G试验)和半乳甘露聚糖(GM试验)对HIV阳性TSM的阳性率为81.8%、70.7%,而HIV阴性TSM的G和GM试验阳性率为18.2%、9.1%。12株TM药敏结果显示泊沙康唑、伊曲康唑、伏立康唑和两性霉素B具有较低的最低抑菌浓度(MIC),棘白菌素类和氟康唑的MIC较高。马尔尼菲篮状菌病病死率为45.5%。结论 TSM患者临床症状和影像学表现无特异性,须尽早进行相关病原学检查,G试验和GM试验对HIV合并TSM的患者具有早期提示诊断价值,及时使用抗真菌治疗对降低病死率具有重要意义。

关键词: 马尔尼菲篮状菌感染, 临床特征, 真菌药敏试验, 预后

Abstract: Objective To understand the clinical features and prognosis of patients with Talaromyces marneffei infection in Longyan, Fujian Province, and provide evidence for early identification and effective treatment of the disease. Methods The data of 44 patients with Talaromyces marneffei infection treated in Longyan first hospital and Longyan Second Hospital Affiliated to Fujian Medical University from January 2017 to November 2021 were collected. It includes general data, clinical manifestations, laboratory examination results, imaging changes, strain identification, drug sensitivity test, treatment and prognosis. Comparison between the two groups by χ2 test or Mann Whitney U test was made. Results Among the 44 patients, 22 were HIV positive and 22 were HIV negative. The significant differences were existed in onset age, clinical symptoms, WBC, CD4+T lymphocytes, HB, PLT, AST, ALT, ALB and PCT between the two groups. The CD4+T lymphocytes of 95.4% AIDS combined with TSM patients was less than 50/μL. The HIV positive group was dominated by disseminated TSM, while the HIV negative group was localized TSM. The positive rates of serum G test and GM test to HIV positive TSM were 81.8% and 70.7%, while they were 18.2% and 9.1% in HIV negative TSM. The MIC values of posaconazole, itraconazole, voriconazole and amphotericin B were lower, and MICs of echinocandins and fluconazole were higher in 12 TM strains. The mortality of Talaromycesis marneffii infection was 45.5%. Conclusion There is no specificity in clinical symptoms and imaging results of TSM patients, so relevant etiological examination should be carried out as soon as possible. G and GM tests have early diagnostic values for AIDS patients with TSM. Timely use of antifungal therapy is of great significance in reducing mortality.

Key words: Talaromycesis marneffii, clinical characteristics, fungal susceptibility test, prognosis

中图分类号: